Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lillian L. Siu
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care Through the Global Alliance for Genomics and Health
Cancer Discovery
Oncology
A Phase I First-In-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Determinants of the Recommended Phase 2 Dose of Molecular Targeted Agents
Cancer
Cancer Research
Oncology
Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era
Oncologist
Cancer Research
Medicine
Oncology
Feasibility Assessment of Using the Complete Patient‐Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO‐CTCAE) Item Library
Oncologist
Cancer Research
Medicine
Oncology
Choice of Starting Dose for Biopharmaceuticals in First-In-Human Phase I Cancer Clinical Trials
Oncologist
Cancer Research
Medicine
Oncology
Phase 1 Study of Ixazomib, an Investigational Proteasome Inhibitor, in Advanced Non-Hematologic Malignancies
Investigational New Drugs
Oncology
Pharmacology
